These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20567206)

  • 1. Antibodies against N-homocysteinylated proteins and their determinants in patients on long-term hemodialysis.
    Kolarz M; Wyroślak J; Zbróg Z; Kraśniak A; Rogulska J; Padjas A
    Pol Arch Med Wewn; 2010 Jun; 120(6):223-30. PubMed ID: 20567206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
    Undas A; Kolarz M; Kopec G; Glowacki R; Placzkiewicz-Jankowska E; Tracz W
    Nephrol Dial Transplant; 2007 Jun; 22(6):1685-9. PubMed ID: 17317712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against Nε-homocysteinylated proteins in patients on different methods of renal replacement therapy.
    Kolarz M; Małyszko J; Stompór T; Całka A; Undas A; Myśliwiec M
    Clin Chem Lab Med; 2013 May; 51(5):1093-9. PubMed ID: 23183756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
    Padjas A; Undas A; Swadzba J; Musiał J
    Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity.
    Nowakowska-Plaza A; Potaczek DP; Gluszko P; Undas A
    Scand J Rheumatol; 2014; 43(1):17-21. PubMed ID: 24015711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of Nε-homocysteinyl-lysine isopeptide in patients on long-term hemodialysis.
    Kolarz M; Głowacki R; Stompór T; Wyroślak J; Undas A
    Clin Chem Lab Med; 2012 Feb; 50(8):1373-8. PubMed ID: 22868801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men.
    Undas A; Jankowski M; Twardowska M; Padjas A; Jakubowski H; Szczeklik A
    Thromb Haemost; 2005 Feb; 93(2):346-50. PubMed ID: 15711753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.
    Lim PS; Chang YM; Thien LM; Wang NP; Yang CC; Chen TT; Hsu WM
    Blood Purif; 2002; 20(6):537-42. PubMed ID: 12566669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
    Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
    Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
    Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
    Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
    Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
    Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of serum homocysteine levels in diabetic patients on haemodialysis.
    Oishi K; Nagake Y; Yamasaki H; Fukuda S; Ichikawa H; Ota K; Makino H
    Nephrol Dial Transplant; 2000 Jun; 15(6):851-5. PubMed ID: 10831640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
    Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
    Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.